Intended Use
The COVID-19 Antigen Rapid Test is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swab, nasal swab or oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider.
Sample
Nasopharyngeal Swab, Nasal Swab, Oropharyngeal Swab
Product Features
- Easy handling, no instrument required.
- Support the detection of 3 different samples.
- Instant results at 15 minutes.
- Results are clearly visible and reliable.
- High sensitivity and specificity.
- Excellent performance compared to molecular methods.
- Room temperature storage.
Product Information
Catalog No. |
Specifications |
Reaction Time |
Sensitivity |
Specificity |
Storage Condition |
Shelf Life |
Certification |
ICOV5002-A001 |
1 test/box |
15 mins
|
For nasopharyngeal swab:
96.0% (95% CI: 93.0%-97.8%)
For nasal swab:
95.5% (95% CI: 89.8%-98.0%)
|
For nasopharyngeal swab:
100% (95% CI: 99.6%-100%)
For nasal swab:
100% (95% CI: 99.2%-100%)
|
4-30℃
|
24 months
|
CE
|
ICOV5002-A005 |
5 tests/box |
ICOV5002-A025 |
25 tests/box |
These products can not be sold in the United States.